+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Differential effects of tamoxifen-like compounds on osteoclastic bone degradation, H+-ATPase activity, calmodulin-dependent cyclic nucleotide phosphodiesterase activity, and calmodulin binding



Differential effects of tamoxifen-like compounds on osteoclastic bone degradation, H+-ATPase activity, calmodulin-dependent cyclic nucleotide phosphodiesterase activity, and calmodulin binding



Journal Of Cellular Biochemistry. 66(3): 358-369



We studied effects of calmodulin antagonists on osteoclastic activity and calmodulin-dependent HCl transport. The results were compared to effects on the calmodulin-dependent phosphodiesterase and antagonist-calmodulin binding affinity. Avian osteoclast degradation of labeled bone was inhibited approximately 40% by trifluoperazine or tamoxifen with half-maximal effects at 1-3 microM. Four benzopyrans structurally resembling tamoxifen were compared: d-centchroman inhibited resorption 30%, with half-maximal effect at approximately 100 nM, cischroman and CDRI 85/287 gave 15-20% inhibition, and l-centchroman was ineffective. No benzopyran inhibited cell attachment or protein synthesis below 10 microM. However, ATP-dependent membrane vesicle acridine transport showed that H(+)-ATPase activity was abolished by all compounds with 50% effects at 0.25-1 microM. All compounds also inhibited calmodulin-dependent cyclic nucleotide phosphodiesterase at micromolar calcium. Relative potency varied with assay type, but d- and l-centchroman, surprisingly, inhibited both H(+)-ATPase and phosphodiesterase activity at similar concentrations. However, d- and l-centchroman effects in either assay diverged at nanomolar calcium. Of benzopyrans tested, only the d-centchroman effects were calcium-dependent. Interaction of compounds with calmodulin at similar concentrations were confirmed by displacement of labeled calmodulin from immobilized trifluoperazine. Thus, the compounds tested all interact with calmodulin directly to varying degrees, and the observed osteoclast inhibition is consistent with calmodulin-mediated effects. However, calmodulin antagonist activity varies between specific reactions, and free calcium regulates specificity of some interactions. Effects on whole cells probably also reflect other properties, including transport into cells.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 008471458

Download citation: RISBibTeXText

PMID: 9257192

DOI: 10.1002/(sici)1097-4644(19970901)66:3<358::aid-jcb8>3.0.co;2-o


Related references

Mechanism for ganglioside mediated modulation of a calmodulin dependent enzyme modulation of calmodulin dependent cyclic nucleotide phosphodiesterase activity through binding of gangliosides to calmodulin and the enzyme. Journal of Biological Chemistry 267(14): 9839-9843, 1992

Heat-stable calmodulin-binding protein in rat testis. Inhibition of calmodulin-stimulated cyclic nucleotide phosphodiesterase activity. Journal of Biological Chemistry 259(14): 9011-9016, 1984

Differential regulation of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase isoenzymes by cyclic AMP-dependent protein kinase and calmodulin-dependent phosphatase. Proceedings of the National Academy of Sciences of the United States of America 82(9): 2603-2607, 1985

Calcium-dependent and -independent interactions of the calmodulin-binding domain of cyclic nucleotide phosphodiesterase with calmodulin. Biochemistry 38(5): 1446-1455, 1999

Inhibitory effect of calcium-binding protein regucalcin on Ca2+/calmodulin-dependent cyclic nucleotide phosphodiesterase activity in rat liver cytosol. Molecular and Cellular Biochemistry 106(1): 25-30, 1991

Function of Calmodulin in Postsynaptic Densities I. Presence of a Calmodulin-Activatable Cyclic Nucleotide Phosphodiesterase Activity. The Journal of Cell Biology 89(3): 433-439, 1981

Comparative effects of calmodulin inhibitors on calmodulin's hydrophobic sites and on the activation of cyclic nucleotide phosphodiesterase by calmodulin. Biochemical Pharmacology 36(12): 1989-1996, 1987

Phosphorylation of calmodulin on Tyr99 selectively attenuates the action of calmodulin antagonists on type-I cyclic nucleotide phosphodiesterase activity. Biochemical Journal 299: 863-868, 1994

Calcium- and calmodulin-independent modulation of calmodulin-sensitive hypothalamic cyclic nucleotide phosphodiesterase activity by the (11-19) fragment of thymosin beta 4. Neurochemical Research 19(4): 451-456, 1994

Inhibitory effect of calcium binding protein regucalcin on calcium calmodulin dependent cyclic nucleotide phosphodiesterase activity in rat liver cytosol. Molecular & Cellular Biochemistry 106(1): 25-30, 1991

Structure-activity relationships of retinoids as inhibitors of calmodulin-dependent human erythrocyte Ca 2+ -Atpase activity and calmodulin binding to membranes. Biochemical Journal 277(3): 603-606, 1991

Structure-activity relationships of retinoids as inhibitors of calmodulin-dependent human erythrocyte Ca(2+)-ATPase activity and calmodulin binding to membranes. Biochemical Journal 277: 603-606, 1991

Calmodulin-dependent cyclic nucleotide phosphodiesterase activity is altered by 20 microT magnetostatic fields. Bioelectromagnetics 24(1): 32-38, 2002

Direct interaction of calmodulin antagonists with Ca2+/calmodulin-dependent cyclic nucleotide phosphodiesterase. Journal of Biochemistry 96(6): 1721-1726, 1984

Direct interaction of calmodulin antagonists with calcium calmodulin dependent cyclic nucleotide phosphodiesterase. Journal of Biochemistry 96(6): 1721-1726, 1984